Opaleye Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
Other funds holding ARIA
Opaleye Management's ARIA Position: Q1 2017 in Review
Opaleye Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 1,000,000 shares — an estimated $12.4M sold.
Opaleye Management first reported a position in ARIA in Q4 2013 and held it in 13 quarters. The position peaked at $14.3M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- Opaleye Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- Opaleye Management sold 1,000,000 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $12.4M.
- Opaleye Management first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 13 quarters.
- Opaleye Management's Ariad Pharmaceuticals Inc position peaked at $14.3M in Q3 2016.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on Opaleye Management's 13F filing for Q1 2017, filed 15 May 2017.